NCT01508988 - Single Dose Escalation Study of ONO-9054 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Conditions

Healthy Adult Subjects

Interventions

DRUG

ONO-9054

Eye drops 0.3 µg/mL both eyes on Day one

DRUG

ONO-9054

Eye drops 1 µg/mL both eyes on Day one

DRUG

ONO-9054

Eye drops 3 µg/mL both eyes on Day one

DRUG

ONO-9054

Eye drops 10 µg/mL both eyes on Day one

DRUG

ONO-9054

Eye drops 20 µg/mL both eyes on Day one

DRUG

ONO-9054

Eye drops 30 µg/mL both eyes on Day one

DRUG

ONO-9054

Matched-placebo eye drops dosed in the same manner as ONO-9054 in both eyes on Day one

Trial Locations (1)

Covance Phase 1 Unit, Dallas